Division of Genetic Medicine and Clinical Pharmacology Archive — Page 8 of 11

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.
June 8, 2022

BioVU celebrates 15 years supporting personalized medicine

BioVU is celebrating its 15th year and has enabled hundreds of studies and publications exploring the genetic underpinnings of a host of conditions including cancer, heart disease and diabetes. 

June 2, 2022

VUMC renewed as a Comprehensive Hypertension Center

The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification,

May 25, 2022

Study seeks to improve gender equity for liver transplantation waiting list

Women who need a liver transplant are more likely to spend more time on a waiting list, become too sick for transplant or die compared to men. To improve equity, a recently published Vanderbilt-led study suggests a sex adjustment to criteria for MELD (model for end-stage liver disease), which determines allocation of transplanted livers.

May 5, 2022

Gene network linked to Type 2 diabetes

Vanderbilt researchers used a novel analytical approach to identify a network of genes associated with Type 2 diabetes, including 31 genes that had not previously been associated with the disease.

Studies by Andrew Glazer, PhD, Giovanni Davogustto, MD, and colleagues found that genetic testing with information from electronic health records can reveal undiagnosed heart rhythm disorders.
April 28, 2022

Studies combine genetic testing, electronic health records to find undiagnosed diseases

Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.

April 14, 2022

VUMC research team receives $1 million grant from AHA to study impact of long-COVID on heart

A research team led by Cyndya Shibao, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center (VUMC), has received a three-year, $1-million grant from the American Heart Association to study long-term effects of COVID-19 on the heart and cardiovascular system.